Showing results (4501-4510 of 9,339) with videos related to

Sort By:
Pageof 934
Cancer Medicine|October 16, 2023
Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trialE Gabriela Chiorean, Vincent Picozzi, Chung-Pin Li, et al.
Cancer Medicine|October 16, 2023
The tumor suppressive effect and apoptotic mechanism of TRAIL gene-containing recombinant NDV in TRAIL-resistant colorectal cancer HT-29 cells and TRAIL-nonresistant HCT116 cells, with each cell bearing a mouse modelBo-Kyoung Jung, Yong Hee An, Sung Hoon Jang, et al.
Cancer Medicine|October 16, 2023
Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myelomaKamlesh Bisht, Taro Fukao, Marielle Chiron, et al.
Cancer Medicine|November 3, 2023
Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myelomaHareth Nahi, Gabriel Afram, Katarina Uttervall, et al.
Cancer Medicine|November 3, 2023
Association between gut microbial change and acute gastrointestinal toxicity in patients with prostate cancer receiving definitive radiation therapyBum-Sup Jang, Moon Gyu Chung, Dong Soo Lee
Cancer Medicine|November 6, 2023
The mitotic cell cycle-associated nomogram predicts overall survival in lung adenocarcinomaXu He, Huafu Zhou, Qianyu Huang, et al.
Cancer Medicine|November 6, 2023
The impact of intensity-modulated radiotherapy in conjunction with chemotherapy on proximal pT3N0 rectal cancer patients after total mesorectum excisionChuan-Yin Fang, Hsuan-Yu Chen, Hsin-Yi Yang, et al.
Cancer Medicine|October 31, 2023
The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group databaseTomoyuki Koguchi, Sei Naito, Shingo Hatakeyama, et al.
Cancer Medicine|November 1, 2023
Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort studyEtienne Guével, Sonia Priou, Guillaume Lamé, et al.
Cancer Medicine|October 31, 2023
Prognostic power assessment of clinical parameters to predict neoadjuvant response therapy in HER2-positive breast cancer patients: A machine learning approachAnnarita Fanizzi, Agnese Latorre, Domenica Antonia Bavaro, et al.
Pageof 934